Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.09.2017 | Case report

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate

Total bilirubin elevation, hepatic encephalopathy and portal hypertensive gastrointestinal bleeding: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Neukam K, et al. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLOS One 11: e0155842, No. 5, 19 May 2016. Available from: URL: http://doi.org/10.1371/journal.pone.0155842 - Spain Neukam K, et al. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLOS One 11: e0155842, No. 5, 19 May 2016. Available from: URL: http://​doi.​org/​10.​1371/​journal.​pone.​0155842 - Spain
Metadaten
Titel
Emtricitabine/rilpivirine/tenofovir disoproxil fumarate
Total bilirubin elevation, hepatic encephalopathy and portal hypertensive gastrointestinal bleeding: 2 case reports
Publikationsdatum
01.09.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-36012-6

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Imiquimod

Case report

Leflunomide

Case report

Trastuzumab

Case report

Natalizumab

Case report

Olanzapine